Literature DB >> 15249339

A role for FDG-PET in the surgical management of stage IV melanoma.

Jeffrey D Wagner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15249339     DOI： 10.1245/ASO.2004.06.923

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Findings from CT, MRI, and PET/CT of a primary malignant melanoma arising in a spinal nerve root.

Authors:  Nyoung Keun Lee; Byung Hoon Lee; Yoon Joon Hwang; Moon-Jun Sohn; Sunhee Chang; Yong Hoon Kim; Soon Joo Cha; Hyeon Je Cho
Journal:  Eur Spine J       Date:  2010-02-03       Impact factor: 3.134

2.  Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.

Authors:  Latifa Rbah-Vidal; Aurélien Vidal; Sophie Besse; Florent Cachin; Mathilde Bonnet; Laurent Audin; Serge Askienazy; Frédéric Dollé; Françoise Degoul; Elisabeth Miot-Noirault; Nicole Moins; Philippe Auzeloux; Jean-Michel Chezal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-16       Impact factor: 9.236

3.  Design, synthesis, and preliminary in vitro and in vivo evaluation of N-(2-diethylaminoethyl)-4-[18F]fluorobenzamide ([18F]-DAFBA): a novel potential PET probe to image melanoma tumors.

Authors:  Sudha Garg; Kanchan Kothari; Shankar R Thopate; Aniruddha K Doke; Pradeep K Garg
Journal:  Bioconjug Chem       Date:  2009-03-18       Impact factor: 4.774

4.  Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.

Authors:  Narges K Tafreshi; Xuan Huang; Valerie E Moberg; Natalie M Barkey; Vernon K Sondak; Haibin Tian; David L Morse; Josef Vagner
Journal:  Bioconjug Chem       Date:  2012-11-27       Impact factor: 4.774
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.